CRIS Current Research Information System

LUNGHI, CARLOTTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.432
NA - Nord America 2.130
EU - Europa 1.414
SA - Sud America 190
AF - Africa 88
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.276
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.023
SG - Singapore 963
CN - Cina 916
VN - Vietnam 658
IT - Italia 598
HK - Hong Kong 265
KR - Corea 207
DE - Germania 185
BR - Brasile 150
IN - India 136
SE - Svezia 129
GB - Regno Unito 92
FR - Francia 90
JP - Giappone 72
CA - Canada 67
BD - Bangladesh 60
IE - Irlanda 53
RU - Federazione Russa 52
NL - Olanda 51
FI - Finlandia 40
CI - Costa d'Avorio 29
MX - Messico 29
AT - Austria 26
BG - Bulgaria 26
TH - Thailandia 23
JO - Giordania 21
ID - Indonesia 20
PH - Filippine 19
ZA - Sudafrica 18
AR - Argentina 17
AU - Australia 16
CH - Svizzera 16
ES - Italia 15
PL - Polonia 15
TR - Turchia 15
IQ - Iraq 10
TG - Togo 10
PK - Pakistan 9
SA - Arabia Saudita 9
MA - Marocco 8
TW - Taiwan 7
UA - Ucraina 7
CL - Cile 5
CO - Colombia 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
SC - Seychelles 5
BE - Belgio 4
EC - Ecuador 4
IR - Iran 4
RS - Serbia 4
CR - Costa Rica 3
DK - Danimarca 3
KE - Kenya 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GT - Guatemala 2
IL - Israele 2
JM - Giamaica 2
MY - Malesia 2
PS - Palestinian Territory 2
PT - Portogallo 2
SN - Senegal 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
BY - Bielorussia 1
DZ - Algeria 1
GH - Ghana 1
HN - Honduras 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MM - Myanmar 1
PE - Perù 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.276
Salva come PNG Salva come JPEG
Città #
Singapore 658
Hefei 453
San Jose 363
Hong Kong 251
Santa Clara 216
Ashburn 209
Ho Chi Minh City 202
Seoul 199
Hanoi 163
Council Bluffs 97
Boardman 95
Bologna 85
Beijing 69
Dallas 69
Tokyo 64
Princeton 59
Lauterbourg 57
New York 55
Los Angeles 54
Dublin 52
Milan 50
Frankfurt am Main 49
Florence 48
Rome 47
Bengaluru 45
Chandler 37
Southend 31
Abidjan 29
Helsinki 26
Nuremberg 26
Redondo Beach 26
Seattle 26
Sofia 26
Buffalo 25
Turin 25
Da Nang 24
Haiphong 24
Fairfield 23
Montreal 22
São Paulo 22
Amman 21
The Dalles 21
Des Moines 20
Ann Arbor 19
Chicago 17
Modena 17
Jakarta 16
London 15
Vienna 15
Woodbridge 15
Forlì 14
Mexico City 14
Tongling 13
Bangkok 12
Shanghai 12
Falkenstein 11
Guangzhou 11
Olalla 11
Orem 11
San Diego 11
Bern 10
Ha Long 10
Houston 10
Lappeenranta 10
Lomé 10
Warsaw 10
Berlin 9
Bühl 9
Cesena 9
Phoenix 9
Phủ Lý 9
San Francisco 9
Amsterdam 8
Atlanta 8
Berkeley 8
Pescara 8
Toronto 8
Wilmington 8
Brakpan 7
Cambridge 7
Medford 7
Quận Bình Thạnh 7
Can Tho 6
Denver 6
Embrun 6
Figino 6
Genoa 6
Istanbul 6
Mumbai 6
Munich 6
Naples 6
Paris 6
Perth 6
Québec 6
Reggio Emilia 6
Rio de Janeiro 6
Stockholm 6
Tianjin 6
Ankara 5
Biên Hòa 5
Totale 4.693
Salva come PNG Salva come JPEG
Nome #
Morbidities and mortality of diagnosed attention deficit hyperactivity disorder (ADHD) over the youth lifespan: A population-based retrospective cohort study 335
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals 322
Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study 276
Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective 196
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 182
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 181
The interface of depression and diabetes: treatment considerations 174
Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency 174
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies 170
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study 164
Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE's key recommendations 150
SYNHETIC IMMUNOGENIC GLYCOCONJUGATE FOR MELANOMA IMMUNOTHERAPY 150
Early career researchers’ perspectives and roles in patient-oriented research 149
Comorbidity, trauma, and mortality in children and young adults using ADHD medications in Quebec between 2000 and 2020 146
Psychotropic medication use pre and post-diagnosis of cluster B personality disorder: a Quebec’s health services register cohort 140
ADHD Medication Use and Psychiatric Comorbidity, Trauma and Mortality in Children and Young Adults: A Cohort Study from Quebec, Canada 133
Definition and validation of case detection algorithms using Quebec medico-administrative databases (med-echo and ramq) for depression among seniors 121
Health care system costs related to potentially inappropriate medication use involving opioids in older adults in Canada 121
Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study 120
Association between stimulant and non-stimulant ADHD medications and completed suicide in adolescents and adults: A population-based nested case-control study 119
ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study 118
Cluster B personality disorders and psychotropic medications: a focused analysis of trends and patterns across sex and age groups 117
Medication use in Italian nursing homes: preliminary results from the national monitoring system 116
LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS 116
Medication use in the year before and after a diagnosis of cluster B personality disorder: Trends and patterns between 2002 and 2018 in Quebec, Canada 113
Trends in medication use during the COVID-19 pandemic in Quebec, Canada 112
What methods are used to study the association between medication adherence trajectories, estimated with the group-based trajectory modeling (GBTM) method, and health-related outcomes?—a protocol for a systematic review 111
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward 111
Global prevalence of antidepressant utilization in the community: A protocol for a systematic review 111
What Is the Safety Profile of Cannabis-Based Medications? Analysis of the Post-Marketing Signals from the FDA Adverse Event Reporting System 110
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health: Pharmaceutical Residues in the Environment: Threats to Ecosystems and Human Health 108
Post-marketing safety profile of cannabis products: Signals from the FDA adverse event reporting system 106
Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada 98
Patient and health system factors associated with potentially inappropriate opioid use in non-cancer community-dwelling older adults 97
Psychiatric and non-psychiatric polypharmacy among older adults with schizophrenia: Trends from a population-based study between 2000 and 2016 96
Multimorbidity Treatment Burden Questionnaire (MTBQ): Translation, Cultural Adaptation, and Validation in French-Canadian 91
Environmental sustainability-an essential component of rational use of medicines 88
Trends of polypharmacy among older adults with schizophrenia in Quebec, Canada between 2000 and 2017 84
Economic evaluations of interventions to optimize medication use in older adults with polypharmacy and multimorbidity: A systematic review 81
Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation 80
Association Between Depression And Discontinuation With Antidiabetic Drugs 75
Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health 73
Incidence of depression and associated factors in patients with type 2 diabetes in Quebec, Canada 72
Exposure to guideline-recommended drugs after a first acute myocardial infarction in older adults: does deprivation matter? 71
Depression and the risk of hospitalization in type 2 diabetes patients: A nested case-control study accounting for non-persistence to antidiabetic treatment 71
Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes: A nested case-control study 70
Scholarly publishing depends on peer reviewers 70
The delicate choice of optimal basic therapy for multimorbid older adults: A cross-sectional survey 67
Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression 66
The impact of incident depression on medication adherence in patients with type 2 diabetes 65
Toward the harmonization of bioequivalence guidelines in Europe: Commentary on the state of the art and future priorities under ICH M13A for immediate‐release oral forms 64
Dosing of Cannabinoids Associated with an Opioid-Sparing Effect: A Systematic Review of Longitudinal Studies 63
The Association Between Depression and Medication Non-Adherence in Type 2 Diabetes: A Population-Based Cohort Study 62
Changes in self-rated physical and mental health and life satisfaction associated with opioid and potentially inappropriate opioid prescribing in primary care older adults 61
The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs 61
Sialylexoenitols as precursors for new analogues of sialidase inhibitors 61
Prevalence of Depression in Patients with Type 2 Diabetes (T2D) in Quebec 61
Use of Quebec medico-administrative databases for mental health studies: Opportunities, methodological challenges and limitations – The case of depression among diabetic subjects 60
Benefits, risks and impacts on quality of life of medications used in multimorbid older adults: a Delphi study 59
From adoption to impact: linking prescribing tools to clinical outcomes—authors’ response 57
Risk of Mortality Associated with Potentially Inappropriate Medication Use Including Opioids in Older Adults 57
Structural study of liposomes loaded with a GM3 lactone analogue for the targeting of tumor epitopes 54
Stereoselective synthesis of 1,3-disaccharides through diels-alder reactions: Part 2[ ]: Convenient protecting groups for heterodienes and conformational evaluations 54
Risk of Psychotic Disorders Among Patients with Medical Cannabis Authorization: A Longitudinal Cohort Study 54
Alternative mechanistic paths in the Hetero-Diels-Alder reaction of α-oxothiones: A theoretical study 52
CoViD-19 pandemic and incidence of depression in people with diabetes: mental health unmet needs? 51
Stable GM3 lactone mimetic raises antibodies specific for the antigens expressed on melanoma cells 51
Treatment sequences in moderate-to-severe psoriasis: a hospital-based retrospective analysis 48
Synthesis, conformational studies, binding assessment and liposome insertion of a thioether-bridged mimetic of the antigen GM3 ganglioside lactone 48
Utilization of Health Care Services by Patients With Cluster B Personality Disorders or Schizophrenia 46
Factors associated with potentially inappropriate opioid use in community-living older adults consulting in primary care 42
Vertigo and Balance Disorders - The Role of Osteopathic Manipulative Treatment: A Systematic Review (vol 23, pg 1, 2020) 21
Totale 7.474
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022363 0 0 3 0 2 0 81 44 24 17 106 86
2022/2023528 38 26 36 42 48 22 47 56 106 43 38 26
2023/2024392 23 35 30 22 31 58 30 21 24 52 46 20
2024/20251.719 104 162 136 104 254 90 103 62 54 83 176 391
2025/20264.403 614 642 438 321 302 167 513 210 503 288 217 188
2026/202759 59 0 0 0 0 0 0 0 0 0 0 0
Totale 7.474